Neuroendocrine tumours trials in Mexico

5 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy

  Where

  Guadalajara, Jalisco, México, Mexico City, Toluca, Zapopan

  Age

  18 years and over

  People

  390 worldwide

  Run by

  Boehringer Ingelheim

  See details and how to joinNCT07544654 · EU 2025-523869-22-00
• Phase 2/3Taking people
  Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

  Where

  Mexico City

  Age

  18 years and over

  People

  440 worldwide

  Run by

  Exelixis

  See details and how to joinNCT06943755 · EU 2025-521043-20-00
• No phaseTaking people
  Neuroendocrine Carcinomas: Patient Journey And Treatment Outcomes In Latin America

  Where

  Mexico City

  Age

  18 years and over

  People

  200 worldwide

  Run by

  Latin American Cooperative Oncology Group

  See details and how to joinNCT07192991
• Phase 2Taking people
  Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

  Where

  Mexico City

  Age

  18 years and over

  People

  141 worldwide

  Run by

  SWOG Cancer Research Network

  See details and how to joinNCT05040360
• No phaseTaking people
  Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients

  Where

  Mexico City

  Age

  18 years and over

  People

  750

  Run by

  Universidad Nacional Autonoma de Mexico

  See details and how to joinNCT06523582